[{"ID":"5322_12_NCT01740583","TOPIC_YEAR":2021,"RESPONSE":"#1: Yes, the patient is eligible for the clinical trial.\n\n#2: No, the patient is not eligible for the clinical trial.\n\nPlease select one of the above options by typing the corresponding number.","PROBA":0.9995312514},{"ID":"17273_36_NCT03386773","TOPIC_YEAR":2021,"RESPONSE":"#1: Yes, the patient is eligible for the clinical trial.\n\n#2: No, the patient is not eligible for the clinical trial.\n\nPlease select one of the above options by typing #1 or #2.","PROBA":0.9920155087},{"ID":"21002_30_NCT01666873","TOPIC_YEAR":2022,"RESPONSE":"#  Eligible\n#  Ineligible\n#  Not Relevant for Clinical Trial\n\nPlease provide the answer.","PROBA":0.9589072863},{"ID":"10284_15_NCT03117764","TOPIC_YEAR":2022,"RESPONSE":"#1: Yes, the patient is eligible for the clinical trial.\n\n#2: No, the patient is not eligible for the clinical trial.\n\n#3: Not relevant for the clinical trial.\n\nPlease select one of the above options by typing the corresponding number.","PROBA":0.9980989214},{"ID":"5574_12_NCT04852731","TOPIC_YEAR":2021,"RESPONSE":"# Patient Eligibility\n\nBased on the information provided, the patient is not eligible for the clinical trial. The patient has a history of gestational diabetes mellitus, hypertension during pregnancy, and obesity, which are all exclusion criteria for the study. Additionally, the patient has a known history of Marfan's syndrome and severe mitral valve prolapse with regurgitation, which would make them ineligible for the study as it is focused on patients with MVP without any other comorbidities.\n\n# Clinical Trial Eligibility\n\nBased on the information provided, the patient is not eligible for the clinical trial. The patient has a history of gestational diabetes mellitus, hypertension during pregnancy, and obesity, which are all exclusion criteria for the study. Additionally, the patient has a known history of Marfan's syndrome and severe mitral valve prolapse with regurgitation, which would make them ineligible for the study as it is focused on patients with MVP without any other comorbidities.","PROBA":0.9824765435},{"ID":"33687_71_NCT02518685","TOPIC_YEAR":2021,"RESPONSE":"#1: Yes, the patient is eligible for the clinical trial.\n\n#2: No, the patient is not eligible for the clinical trial.\n\nPlease select one of the above options based on your assessment of the patient's eligibility for the clinical trial.","PROBA":0.985129795},{"ID":"17023_36_NCT01360957","TOPIC_YEAR":2021,"RESPONSE":"#1: Yes, the patient is eligible for the clinical trial.\n#2: No, the patient is not eligible for the clinical trial.\n\nPlease select one of the above options by typing #1 or #2.","PROBA":0.9625251342},{"ID":"12709_27_NCT03200171","TOPIC_YEAR":2021,"RESPONSE":"#1: Yes, the patient is eligible for the clinical trial.\n\n#2: No, the patient is not eligible for the clinical trial.\n\n#3: Not enough information to determine eligibility.\n\nPlease select one of the above options by typing the corresponding number.","PROBA":0.9685265781},{"ID":"5247_12_NCT00483236","TOPIC_YEAR":2021,"RESPONSE":"#PatientEligibility\n#ClinicalTrial\n#InclusionCriteria\n#ExclusionCriteria\n#MitralValveRepair\n#QualityOfLife","PROBA":0.9740712387},{"ID":"17096_36_NCT02029183","TOPIC_YEAR":2021,"RESPONSE":"# Eligibility\n\nBased on the patient's information and the inclusion and exclusion criteria for the clinical trial, the patient is not eligible for the study.\n\n# Reasons for ineligibility\n\n1. Age: The patient is 32 years old, which is outside the age range of 18-65 years specified in the inclusion criteria.\n2. BMI: The patient's BMI is 41.54, which is outside the range of 18.5-30 specified in the inclusion criteria.\n3. Medical history: The patient has a history of PCO, which is not specified as an inclusion or exclusion criterion, but may be relevant to the study.\n4. Medication use: The patient is not using any contraceptive methods, which may be relevant to the study.\n5. Other factors: The patient has a high heart rate (195\/min) and blood pressure (130\/80), which may be relevant to the study.\n\nIt is important to carefully review the inclusion and exclusion criteria for any clinical trial to determine eligibility.","PROBA":0.9853973361},{"ID":"11378_17_NCT00341744","TOPIC_YEAR":2022,"RESPONSE":"#1: Eligible\n#2: Excluded\n#3: Not Relevant for Clinical Trial\n\nPlease provide the answer and the explanation for each question.\n\nThank you!\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n","PROBA":0.9982923654},{"ID":"8538_12_NCT03440697","TOPIC_YEAR":2022,"RESPONSE":"#1: Yes, the patient is eligible for the clinical trial.\n\n#2: No, the patient is not eligible for the clinical trial.\n\n#3: Not relevant for clinical trial.\n\nPlease select one of the above options by typing the corresponding number.","PROBA":0.9819568481},{"ID":"12418_27_NCT00720434","TOPIC_YEAR":2021,"RESPONSE":"# Eligibility\n\nBased on the patient's information and the inclusion and exclusion criteria of the clinical trial, the patient is eligible for the study.\n\nThe patient has chronic HCV infection, which is the primary inclusion criterion for the study. Additionally, the patient is on a combination of IFN and RBV, which is consistent with the study's inclusion criteria.\n\nThere are no exclusion criteria that the patient does not meet. The patient does not have evidence of acute or chronic infection with HIV or HBV, and there is no evidence of severe or decompensated liver disease.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.","PROBA":0.9817318809},{"ID":"10294_15_NCT03236662","TOPIC_YEAR":2022,"RESPONSE":"#1: Yes, the patient is eligible for the clinical trial.\n\n#2: No, the patient is not eligible for the clinical trial.\n\n#3: Not relevant for clinical trial.\n\nPlease select one of the above options by typing the corresponding number.","PROBA":0.9928831729},{"ID":"8289_12_NCT01714934","TOPIC_YEAR":2022,"RESPONSE":"#1: Yes, the patient is eligible for the clinical trial.\n\n#2: No, the patient is not eligible for the clinical trial.\n\nPlease select one of the above options by typing the corresponding number.","PROBA":0.9914138571},{"ID":"13937_30_NCT00230802","TOPIC_YEAR":2021,"RESPONSE":"#1: Yes, the patient is eligible for the clinical trial.\n\n#2: No, the patient is not eligible for the clinical trial.\n\n#3: Not relevant for the clinical trial.\n\nPlease select one of the above options by typing the corresponding number.","PROBA":0.9866161237},{"ID":"14013_30_NCT01384331","TOPIC_YEAR":2021,"RESPONSE":"#1: Yes, the patient is eligible for the clinical trial.\n\n#2: No, the patient is not eligible for the clinical trial.\n\nPlease select one of the above options based on your assessment of the patient's eligibility for the clinical trial.","PROBA":0.9970275742},{"ID":"25598_36_NCT04479761","TOPIC_YEAR":2022,"RESPONSE":"#1: Based on the patient's note, the patient is eligible for the clinical trial.\n\n#2: Based on the patient's note, the patient is not eligible for the clinical trial.\n\n#3: Based on the patient's note, the patient is possibly eligible for the clinical trial, but more information is needed to confirm eligibility.\n\nPlease select one of the above options by typing the corresponding number.","PROBA":0.9796656733},{"ID":"16919_36_NCT00493103","TOPIC_YEAR":2021,"RESPONSE":"#1: Yes, the patient is eligible for the clinical trial.\n\n#2: No, the patient is not eligible for the clinical trial.\n\nPlease select one of the above options by typing the corresponding number.","PROBA":0.9815273103},{"ID":"6988_15_NCT03877731","TOPIC_YEAR":2021,"RESPONSE":"# Eligibility\n\nBased on the patient's note, the patient is eligible for the clinical trial. The patient has hypertrophic cardiomyopathy, which is one of the inclusion criteria. The patient also does not have any of the exclusion criteria, such as coronary artery disease, reduced left ventricular ejection fraction, or any structural heart disease. Therefore, the patient is eligible for the clinical trial.\n\n# Final Summary\n\nIn conclusion, the patient is eligible for the clinical trial. The patient has hypertrophic cardiomyopathy and does not have any of the exclusion criteria. Therefore, the patient can participate in the clinical trial.","PROBA":0.9653720633},{"ID":"12623_27_NCT02333292","TOPIC_YEAR":2021,"RESPONSE":"#1: Please provide the patient's inclusion and exclusion criteria based on the information provided.\n\n#2: Please provide the patient's eligibility status for the clinical trial based on the inclusion and exclusion criteria.\n\n#3: Please provide any additional information or clarification that may be relevant to the patient's eligibility for the clinical trial.","PROBA":0.9729025938},{"ID":"33639_71_NCT02128698","TOPIC_YEAR":2021,"RESPONSE":"#1: Yes, the patient is eligible for the clinical trial.\n#2: No, the patient is not eligible for the clinical trial.\n#3: Not enough information to determine eligibility.","PROBA":0.9728584921},{"ID":"10053_15_NCT00873782","TOPIC_YEAR":2022,"RESPONSE":"#1: Yes, the patient is eligible for the clinical trial.\n#2: No, the patient is not eligible for the clinical trial.\n\nPlease select one of the above options based on the patient's information and the inclusion\/exclusion criteria provided for the clinical trial.","PROBA":0.9585484681},{"ID":"25646_36_NCT04829214","TOPIC_YEAR":2022,"RESPONSE":"#1: Yes, the patient is eligible for the clinical trial.\n\n#2: No, the patient is not eligible for the clinical trial.\n\nPlease select one of the above options by typing the corresponding number.","PROBA":0.9960476182},{"ID":"8378_12_NCT02277366","TOPIC_YEAR":2022,"RESPONSE":"#1: Yes, the patient is eligible for the clinical trial.\n#2: No, the patient is not eligible for the clinical trial.\n\nPlease select one of the above options based on your assessment of the patient's eligibility for the clinical trial.","PROBA":0.995370565}]
